Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

21:39 EDT 21st October 2014 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 400,000+

Tuesday 21st October 2014

Rheumatoid arthritis: Choline kinase—more than a cancer therapy target?

Sucampo, Takeda make Amitiza deal global

Takeda now has a license for Amitiza in all markets except for Japan and China. The Japanese pharma company will fund all development, regulatory and commercial activities after an initial $6m investment by Bethesda, Maryland-based Sucampo, which wil...

Mechanisms of neuroblastoma regression

Recent studies of neuroblastoma have shed light on the dramatic heterogeneity in its clinical behaviour, which spans from spontaneous regression or differentiation to relentless disease progression. This Review describes the different mechanisms of s...

Gastrointestinal cancer: FOLFIRI—improving toxicity in first-line treatment of advanced gastric cancer

Skin cancer: BRAF and MEK inhibitors—good news comes in twos!

Screening: NELSON shows less is more in lung cancer screening

UPDATE 6-U.S. to funnel travelers from Ebola-hit region through 5 airports

NEW YORK, Oct 21 (Reuters) - The United States ratcheted up its safeguards against Ebola on Tuesday, requiring travelers from three countries at the center of an epidemic in West Africa to fly into one of five major airports conducting enhanced scree...

PRESS DIGEST- Financial Times - Oct 22

Oct 22 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

PRESS DIGEST- British Business - Oct 22

Oct 22 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Autophagy and Burkholderia

Autophagy as a pro-death pathway

Jury deliberations begin in first trial over DePuy's Pinnacle hips

Oct 21 (Reuters) - A lawyer for a Montana woman on Tuesday urged jurors in a U.S. court to find Johnson & Johnson's DePuy Orthopaedics unit liable for failing to warn patients that metal-on-metal Pinnacle hip implants were defective at the close of t...

UPDATE 5-U.S. to funnel travelers from Ebola-hit region through 5 airports

(Adds upgrade in nurse's medical condition, White House comments on travel ban, industry comment)

Sellas signs up PPD as a preferred partner

Swiss-based Sellas Life Sciences Group has signed a definitive master service agreement with CRO Pharmaceutical Product Development (PPD) to advance and expand clinical and regulatory development.

FDA to combine all of its quality ops under a new ‘super’ office

By early next year the US FDA is set to launch a new “super” office known as OPQ (Office of Pharmaceutical Quality), which will better align the review, inspection, and research of drugs.

NBC freelance cameraman Mukpo free of Ebola -Nebraska hospital

Oct 21 (Reuters) - Ebola patient Ashoka Mukpo, an NBC freelance cameraman, is free of the virus and will leave the Nebraska Medical Center on Wednesday, the hospital said.

Do mid-size CROs have business model problems? One CEO thinks so

Squeezed by the pressure of shorter deadlines and higher quality expectations, as well as by competition from larger peers, mid-size CROs may need to think more about innovation to stay ahead, a CEO of a mid-size CRO told us.

Parexel pushes further into UK with new grants, Nottingham office

Little more than a week after purchasing the UK RTSM provider ClinIntel , Parexel has secured new office space in Nottingham, UK and won grants totalling £1m ($1.6m). 

UPDATE 1-FDA panel votes to expand use of Vertex cystic fibrosis drug

Oct 21 (Reuters) - A U.S. Food and Drug Administration advisory panel on Tuesday voted 13-2 to recommend expanding approval of Vertex Pharmaceuticals Inc's cystic fibrosis drug Kalydeco to include a wider range of patients with the rare lung disease,...

Genetic screens: CRISPR screening from both ways

Evolution: Evidence of group selection shown in social spiders

UPDATE 2-Intuitive Surgical 3rd-quarter sales top Wall St estimates

Oct 21 (Reuters) - Intuitive Surgical Inc on Tuesday showed signs of bouncing back from a difficult first half of the year as sales of its da Vinci robotic surgical systems increased in the third quarter, as did procedures using the company's high-pr...

BRIEF-Takeda and Sucampo enter into global licensing agreement for Amitiza

* Takeda and Sucampo enter into global licensing agreement for Amitiza

Ebola nurse's status upgraded to good from fair

NEW YORK (Reuters) - The medical status of nurse Nina Pham, who contracted Ebola when she helped treat the first patient to be diagnosed with the disease on U.S. soil, was upgraded to good from fair on Tuesday, the National Institutes of Health (NIH)...

Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin

Search BioPortfolio: